Taiga Nishihori, MD, senior member in the Blood & Marrow Transplant and Cellular Immunotherapy Department at Moffitt Cancer ...
Adam C. Berger, MD, FACS, highlights the challenges and advancements in diagnosing and treating sarcoma, a rare and diverse ...
During a Case-Based Roundtable® event, Daniel George, MD, discussed the results of the CheckMate 9ER trial across favorable, ...
Small cell lung cancer poses a significant challenge across the world, particularly in low-middle-income countries where it ...
Corey Cutler, MD, MPH, and Hannah Choe, MD, provide future perspectives on the development of axatilimab for patients with ...
Robert Jotte, MD, PhD, discussed findings from the phase 3 KRYSTAL-12 study evaluating adagrasib vs docetaxel in previously ...
Alexandra Gomez Arteaga, MD, discusses the rationale behind a retrospective study comparing Orca-T with posttransplant ...
The FDA has granted a rare pediatric disease designation to SLS009 for treating pediatric acute myeloid leukemia.
Francis P. Worden, MD, discusses future plans to investigate combination therapies and other novel treatments in the thyroid ...
A dendritic cell vaccine called DOC1021 shows early promise in treating pancreatic cancer and has received a fast track ...
In this episode of Targeted Talks, Omid Hamid, MD, discusses data supporting the use of lifileucel for the treatment of ...
During a Case-Based Roundtable® event, Andrew Yee, MD, discussed the use of carfilzomib-based regimens compared with other ...